The NYSE Arca Equal Weighted Pharmaceutical Index (DGE) - Quarterly Rebalancing			
"Changes effective before the open of trading Monday, June 24, 2013"			
----------			
Symbol	Component Name	Previous Share Weight	Rebalanced Share Weight
ABBV	AbbVie Inc	Addition	230
ABT	Abbott Laboratories	350	275
ACT	Actavis Inc	Addition	81
AGN	Allergan Inc/United States	110	106
AZN	AstraZeneca PLC	257	203
BMY	Bristol-Myers Squibb Co	307	214
FRX	Forest Laboratories Inc	314	240
GSK	GlaxoSmithKline PLC	264	199
JNJ	Johnson & Johnson	151	118
LLY	Eli Lilly & Co	217	196
MRK	Merck & Co Inc	271	208
MYL	Mylan Inc/PA	Addition	320
NVO	Novo Nordisk A/S	68	64
NVS	Novartis AG	171	141
PFE	Pfizer Inc	426	344
PRGO	Perrigo Co	Addition	82
SHPG	Shire PLC	130	103
SNY	Sanofi	239	191
TEVA	Teva Pharmaceutical Industries Ltd	293	253
VRX	Valeant Pharmaceuticals International Inc	171	116
			
Additions			
ABBV	AbbVie Inc		
ACT	Actavis Inc		
MYL	Mylan Inc/PA		
PRGO	Perrigo Co		
			
Deletions			
(None)